Jump to content

Digoxin: A Timeless Cardiac Glycoside In Modern Therapeutics: Revision history

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

2 May 2026

  • curprev 10:0410:04, 2 May 2026 CesarMulga talk contribs 9,097 bytes +9,097 Created page with "Introduction: The Foxglove's Enduring Legacy<br><br>Digoxin, a cardiac glycoside derived from the leaves of the Digitalis lanata plant (foxglove), stands as one of the most enduring and paradoxically controversial agents in the pharmacopeia. Its clinical use, dating back to William Withering's 1785 treatise on the medicinal properties of foxglove, represents a remarkable journey from herbal remedy to a molecule with a well-defined, yet complex, mechanism of action. In th..."
Retrieved from "https://prophet-of-ai.com/index.php?title=Digoxin:_A_Timeless_Cardiac_Glycoside_In_Modern_Therapeutics"